Evidence map›Paper›PMID 35804988›Full record

ReviewCancers2022

Combining Molecular, Imaging, and Clinical Data Analysis for Predicting Cancer Prognosis.

Barbara Lobato-Delgado, Blanca Priego-Torres, Daniel Sanchez-Morillo

Abstract readReview
In one paragraph

Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. What are you looking at? Modality contribution in multimodal medical deep learning.International journal of computer assisted radiology and surgery · 2026
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Application of Artificial Intelligence Software to Identify Emotions of Lung Cancer Patients in Preoperative Health Education: A Cross-Sectional Study.Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing · 2025
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Barbara Lobato-DelgadoUnitat de Genòmica de Malalties Complexes, Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, 08041 Barcelona, Spain.ORCID 0000-0001-6218-5774
Blanca Priego-TorresDepartment of Automation Engineering, Electronics and Computer Architecture and Networks, Universidad de Cádiz, Puerto Real, 11519 Cádiz, Spain.ORCID 0000-0003-1609-0429
Daniel Sanchez-MorilloDepartment of Automation Engineering, Electronics and Computer Architecture and Networks, Universidad de Cádiz, Puerto Real, 11519 Cádiz, Spain.ORCID 0000-0001-5603-0936

Funding

Consejería de Salud y Familias PI-0032-2017University of Cádiz Plan Propio - UCA 2022-2023.
6 · The paper itself

Abstract

Cancer is one of the most detrimental diseases globally. Accordingly, the prognosis prediction of cancer patients has become a field of interest. In this review, we have gathered 43 state-of-the-art scientific papers published in the last 6 years that built cancer prognosis predictive models using multimodal data. We have defined the multimodality of data as four main types: clinical, anatomopathological, molecular, and medical imaging; and we have expanded on the information that each modality provides. The 43 studies were divided into three categories based on the modelling approach taken, and their characteristics were further discussed together with current issues and future trends. Research in this area has evolved from survival analysis through statistical modelling using mainly clinical and anatomopathological data to the prediction of cancer prognosis through a multi-faceted data-driven approach by the integration of complex, multimodal, and high-dimensional data containing multi-omics and medical imaging information and by applying Machine Learning and, more recently, Deep Learning techniques. This review concludes that cancer prognosis predictive multimodal models are capable of better stratifying patients, which can improve clinical management and contribute to the implementation of personalised medicine as well as provide new and valuable knowledge on cancer biology and its progression.

Indexed as

Artificial Intelligencecancerdata integrationmachine learningmultimodal datapatient risk stratificationprognosis predictionsurvival analysis

Identifiers

PMID35804988
PMCPMC9265023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.